October 07, 2009
Welchol gains pediatric indication
Additionally, the FDA has approved Welchol (colesevelam HCl) for Oral Suspension. In addition to the pediatric indication, Welchol tablets and oral suspension are indicated for use as an adjunct to diet and exercise in adults to reduce elevated LDL-C in primary hypercholesterolemia (Fredrickson Type IIa), alone or with a statin. Welchol is also indicated for use as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes in combination with metformin, sulfonylureas, or insulin.
For more information call (877) 437-7763 or visit www.welchol.com.